Overview

Staccato Alprazolam Single Dose PK

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
We are developing Staccato Alprazolam for the acute treatment of panic attacks associated with panic disorder.
Phase:
Phase 1
Details
Lead Sponsor:
Alexza Pharmaceuticals, Inc.
Treatments:
Alprazolam